Femasys

Femasys

Medical Devices, 3950 Johns CRK Ct, Suwanee, Georgia, 30024, United States, 11-50 Employees

femasys.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 87********

Who is FEMASYS

Femasys is a biomedical company focused on transforming womens healthcare worldwide by developing novel solutions and next-generation advancements providing significant clinical impact to...

Read More

map
  • 3950 Johns CRK Ct, Suwanee, Georgia, 30024, United States Headquarters: 3950 Johns CRK Ct, Suwanee, Georgia, 30024, United States
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $25 Million to $50 Million

industries-icon Industry: Medical Devices

SIC SIC Code: 3841 | NAICS Code: 423450 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from FEMASYS

Femasys Org Chart and Mapping

Employees

Kathy Lee-Sepsick

President & CEO (Founder)

Nathaniel Barnes

Product Development Engineering Technician

Shruti Kumar

Associate Product Manager

Kalpana Soni

Clinical Research Assistant

Anne Frost

Director, Clinical Research

Jeremy Sipos

Vice President, Research and Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Femasys

Answer: Femasys's headquarters are located at 3950 Johns CRK Ct, Suwanee, Georgia, 30024, United States

Answer: Femasys's phone number is 87********

Answer: Femasys's official website is https://femasys.com

Answer: Femasys's revenue is $25 Million to $50 Million

Answer: Femasys's SIC: 3841

Answer: Femasys's NAICS: 423450

Answer: Femasys has 11-50 employees

Answer: Femasys is in Medical Devices

Answer: Femasys contact info: Phone number: 87******** Website: https://femasys.com

Answer: Femasys is a biomedical company focused on transforming womens healthcare worldwide by developing novel solutions and next-generation advancements providing significant clinical impact to address severely underserved areas. With an initial focus in the area of reproductive health, its two lead product candidates offer solutions to improve patient care and health economics: FemBloc, a first and only non-surgical product for permanent birth control and FemaSeedTM, a first and only directed sperm delivery product for infertility treatment. Femasys FemVue product for fallopian tube assessment by ultrasound is currently marketed in the United States as its main commercial priority. Femasys has also developed a novel technology platform for tissue sampling intended to be marketed alongside our other women-specific medical products in the physicians office setting.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access